{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:38Z","timestamp":1783098458534,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,30]]},"DOI":"10.7759\/cureus.74852","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T20:47:27Z","timestamp":1732999647000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Post-COVID Mucormycosis in a Diabetic Patient in Pakistan"],"prefix":"10.7759","author":[{"given":"Bakhtawar","family":"Awan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elsaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes MZ","year":"2011","unstructured":"Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011, 24:411-45. 10.1128\/CMR.00056-10","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid G","year":"2020","unstructured":"Reid G, Lynch JP 3rd, Fishbein MC, Clark NM. Mucormycosis. Semin Respir Crit Care Med. 2020, 41:99-114. 10.1055\/s-0039-3401992","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-019-00403-1","article-title":"Outbreaks of Mucorales and the species involved","volume":"185","author":"Walther G","year":"2020","unstructured":"Walther G, Wagner L, Kurzai O. Outbreaks of Mucorales and the species involved. Mycopathologia. 2020, 185:765-81. 10.1007\/s11046-019-00403-1","journal-title":"Mycopathologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv133.336","article-title":"Determining the incubation time of mucormycosis: a systematic review","volume":"2","author":"Smith RM","year":"2015","unstructured":"Smith RM, Lee J, Mody RK. Determining the incubation time of mucormycosis: a systematic review. Open Forum Infect Dis. 2015, 2:461. 10.1093\/ofid\/ofv133.336","journal-title":"Open Forum Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos G","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54:S23-34. 10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:26. 10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes JA","year":"2000","unstructured":"Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000, 13:236-301. 10.1128\/CMR.13.2.236","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/BF00335563","article-title":"Isolated zygomycosis in a bought living unrelated kidney transplant","volume":"9","author":"Stas KJ","year":"1996","unstructured":"Stas KJ, Louwagie PG, Van Damme BJ, Coosemans W, Waer M, Vanrenterghem YF. Isolated zygomycosis in a bought living unrelated kidney transplant. Transpl Int. 1996, 9:600-2. 10.1007\/BF00335563","journal-title":"Transpl Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02473-06","article-title":"Impact of zygomycosis on microbiology workload: a survey study in Spain","volume":"45","author":"Torres-Narbona M","year":"2007","unstructured":"Torres-Narbona M, Guinea J, Mart\u00ednez-Alarc\u00f3n J, Mu\u00f1oz P, Gadea I, Bouza E. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol. 2007, 45:2051-3. 10.1128\/JCM.02473-06","journal-title":"J Clin Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182867d13","article-title":"Utility of 18F-FDG PET\/CT in diagnosis and management of mucormycosis","volume":"38","author":"Liu Y","year":"2013","unstructured":"Liu Y, Wu H, Huang F, Fan Z, Xu B. Utility of 18F-FDG PET\/CT in diagnosis and management of mucormycosis. Clin Nucl Med. 2013, 38:e370-1. 10.1097\/RLU.0b013e3182867d13","journal-title":"Clin Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2018.01.001","article-title":"Imaging features of rhinocerebral mucormycosis: a study of 43 patients","volume":"49","author":"Therakathu J","year":"2018","unstructured":"Therakathu J, Prabhu S, Irodi A, Sudhakar SV, Yadav VK, Rupa V. Imaging features of rhinocerebral mucormycosis: a study of 43 patients. EJRNM. 2018, 49:447-52. 10.1016\/j.ejrnm.2018.01.001","journal-title":"EJRNM"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh TJ","year":"2012","unstructured":"Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012, 54:S55-60. 10.1093\/cid\/cir868","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12466","article-title":"Why is mucormycosis more difficult to cure than more common mycoses?","volume":"20","author":"Katragkou A","year":"2014","unstructured":"Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses?. Clin Microbiol Infect. 2014, 20:74-81. 10.1111\/1469-0691.12466","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324%2Fhaematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot F","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, et al.. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. haematologica. 2017, 102:433. 10.3324%2Fhaematol.2016.152900","journal-title":"haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"Sipsas NV","year":"2018","unstructured":"Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Therapy of mucormycosis. J Fungi (Basel). 2018, 4:90. 10.3390\/jof4030090","journal-title":"J Fungi (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00837-0","article-title":"Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis","volume":"6","author":"Soliman SS","year":"2021","unstructured":"Soliman SS, Baldin C, Gu Y, et al.. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis. Nat Microbiol. 2021, 6:313-26. 10.1038\/s41564-020-00837-0","journal-title":"Nat Microbiol"},{"key":"ref18","unstructured":"Over 2,000 cases, 8 deaths from Mucormycosis in Maharashtra so far, govt creating special wards. health minister Tope. (2024). Accessed: October 8, 2024: https:\/\/www.hindustantimes.com\/cities\/mumbai-news\/over-2-000-cases-8-deaths-from-mucormycosis-in-maharashtra-so-far-g...."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world","volume":"186","author":"Muthu V","year":"2021","unstructured":"Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia. 2021, 186:739-54. 10.1007\/s11046-021-00584-8","journal-title":"Mycopathologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.29390\/001c.84260","article-title":"Inhaled corticosteroids' effect on COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials","volume":"59","author":"Badi Y","year":"2023","unstructured":"Badi Y, Hammad M, Tawfik AG, et al.. Inhaled corticosteroids' effect on COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Can J Respir Ther. 2023, 59:154-66. 10.29390\/001c.84260","journal-title":"Can J Respir Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1238","article-title":"Covid-19: India sees record deaths as \"black fungus\" spreads fear","volume":"373","author":"Dyer O","year":"2021","unstructured":"Dyer O. Covid-19: India sees record deaths as \"black fungus\" spreads fear. BMJ. 2021, 373:n1238. 10.1136\/bmj.n1238","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jof8020194","article-title":"Global cutaneous mucormycosis: a systematic review","volume":"8","author":"Skiada A","year":"2022","unstructured":"Skiada A, Drogari-Apiranthitou M, Pavleas I, Daikou E, Petrikkos G. Global cutaneous mucormycosis: a systematic review. J Fungi (Basel). 2022, 8:194. 10.3390\/jof8020194","journal-title":"J Fungi (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2021.07.009","article-title":"Mucormycosis-an opportunistic infection in the aged immunocompromised individual: a reason for concern in COVID-19","volume":"154","author":"Chavda VP","year":"2021","unstructured":"Chavda VP, Apostolopoulos V. Mucormycosis-an opportunistic infection in the aged immunocompromised individual: a reason for concern in COVID-19. Maturitas. 2021, 154:58-61. 10.1016\/j.maturitas.2021.07.009","journal-title":"Maturitas"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27522","article-title":"Mucormycosis in COVID-19 recovered patients","volume":"94","author":"Kumar A","year":"2022","unstructured":"Kumar A. Mucormycosis in COVID-19 recovered patients. J Med Virol. 2022, 94:1272-3. 10.1002\/jmv.27522","journal-title":"J Med Virol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: mucormycosis in COVID-19 times","volume":"69","author":"Ravani SA","year":"2021","unstructured":"Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021, 69:1563-8. 10.4103\/ijo.IJO_310_21","journal-title":"Indian J Ophthalmol"},{"key":"ref27","article-title":"Invasive fungal infections in patients with COVID- 19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes","volume":"44","author":"Chiurlo M","year":"2021","unstructured":"Chiurlo M, Mastrangelo A, Ripa M, Scarpellini P. Invasive fungal infections in patients with COVID- 19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes. New Microbiol. 2021, 44:71-83.","journal-title":"New Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3201%2Feid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349. 10.3201%2Feid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Corzo-Le\u00f3n DE","year":"2018","unstructured":"Corzo-Le\u00f3n DE, Chora-Hern\u00e1ndez LD, Rodr\u00edguez-Zulueta AP, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: epidemiology, diagnosis, and outcomes of reported cases. Med Mycol. 2018, 56:29-43. 10.1093\/mmy\/myx017","journal-title":"Med Mycol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306742-a-case-of-post-covid-mucormycosis-in-a-diabetic-patient-in-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T20:47:29Z","timestamp":1732999649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306742-a-case-of-post-covid-mucormycosis-in-a-diabetic-patient-in-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.74852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,30]]}}}